When evaluating medical grade burn gel performance, clinicians, first responders, and procurement teams typically focus on a core set of questions: how quickly does the product dissipate heat, how long does it maintain contact with the wound, what safety and sterilization standards does it meet, and how consistent is its physical performance across batches. Roosin Medical Co., Ltd., a medical device manufacturer specializing in water-based sterile gel and dressing products for burn and scald emergency care, has built its product matrix around these exact performance benchmarks. This review examines how Roosin's formulation technology, product variations, and certification profile translate into measurable performance outcomes for degree I and II burn and scald wounds.
Why Performance Comparison Matters for Burn Gel Selection
Burn and scald injuries require prompt heat dissipation, pain relief, moisture retention, and protection from airborne contamination. Degree I and II burns are typically managed with emergency cooling, while degree III burns require direct medical attention. Because these wounds are time-sensitive, the physical behavior of a burn gel—how it flows, how long it stays on the wound, and how it interacts with heat—directly affects the quality of emergency care. Roosin Medical's positioning as a provider of water-based sterile gel and dressing products reflects this understanding, with each product engineered around a shared technology platform but differentiated by format and application scenario.
The Water-Based Formula Behind Roosin's Performance Profile
At the center of Roosin's product performance is its proprietary water-based gel formulation, composed of 90% purified water combined with medical grade silicone oil emulsion, water soluble azone, glycerol, and propylene glycol. This composition is designed to deliver a cooling effect similar to water while remaining thick and flow-resistant once applied, allowing the gel to stay in place on the wound rather than running off. This sustained contact is what enables continuous heat absorption and ongoing pain relief, rather than a single momentary cooling effect.
In terms of measurable physical properties, Roosin's gel presents as a white or yellowish clear homogeneous liquid, with a viscosity of 5000–30000 mPa·s at 25±2°C and a pH of 5.0–7.5. These parameters are consistent across the product line and are maintained through gamma irradiation sterilization, with the dressing format required to remain sterile. This combination of viscosity and pH is central to the product's dual function: remaining thick enough to stay on the wound surface while maintaining a pH profile suitable for contact with injured skin.
Comparing Roosin's Three Core Products
Roosin Medical's burn and scald emergency care line includes three distinct products—Relieve Burn Gel, Burn Dressing, and Sterile Burn Gel—each built on the same water-based gel technology but offering different formats and emphasis.
Relieve Burn Gel is available in gel sachet (0.9g and 3.5g), spray bottle (50g, 59g, 118g, 120g, and 125g), and dressing formats (2g to 750g, with sizes ranging from 2.5cm×5cm to 30cm×40cm). Its differentiated value lies in rapid heat dissipation to help prevent deeper skin penetration, sustained cooling through its thick gel consistency, and skin moisturization from its silicone oil emulsion, water soluble azone, glycerol, and propylene glycol content.
Burn Dressing emphasizes a water evaporation mechanism for heat absorption and release, cooling the skin while keeping the wound moist and preventing dryness. It is offered in gel format (0.9g and 3.5g) and dressing sizes identical to the Relieve Burn Gel range. A notable feature is its packaging, an aluminum foil bag composed of PET/aluminum foil/PE three-layer composite, supporting a shelf life of 5 years under storage conditions of relative humidity not more than 80% and temperature between 0°C and 40°C.
Sterile Burn Gel places additional emphasis on airborne contamination protection, forming a gel layer that keeps the wound moist while preventing dryness and cracking. It is available in gel (0.9g and 3.5g), spray (50g, 59g, 118g, 120g, and 125g), and dressing formats (sizes from 2.5cm×5cm to 30cm×40cm). This product is backed by comprehensive CE technical documentation, with the notified body identifier 0197 indicated in the product instructions, and is distributed in the EU through authorized representative Prolinx GmbH.
Across all three products, the physical and sterilization parameters—90% purified water content, gamma or irradiation sterilization, and one-time-use sterile packaging—remain consistent, reducing the risk of cross-infection and ensuring predictable performance regardless of which format is selected for a given emergency scenario.
Safety Parameters and Usage Limits
Performance comparison also requires attention to usage boundaries. Across the product line, duration of one continuous contact is not more than 2 hours, with repeated duration of contact not exceeding 12 hours. None of the products are intended for degree III burns, and all require discontinuation if irritation or discomfort occurs, with medical advice sought for severe reactions. For chemical burns, the instructions consistently specify that liquid chemical exposure should be irrigated with cold water for approximately 15–20 minutes, and powder chemicals should be brushed off and the site washed before gel application—demonstrating a standardized safety protocol across the entire line.
Storage conditions are similarly aligned: products should be kept at temperatures between 0°C and 40°C, with humidity not exceeding 80%, in a ventilated room free of corrosive gases. These consistent parameters allow users to apply the same storage and handling standards regardless of which Roosin product is deployed.
Quality and Regulatory Standing
Roosin Medical's performance claims are supported by its ISO 13485 quality management system certification for medical devices, its CE Marking compliance with EU MDR/MDD standards, and its adherence to FDA regulatory requirements. These certifications, combined with the standardized gamma irradiation sterilization process and one-time-use packaging across all three products, form the regulatory backbone supporting the company's stated performance claims regarding heat absorption, pain relief, and contamination protection.
Conclusion
For procurement teams and emergency responders comparing medical grade burn gel performance, Roosin Medical's product line offers a structured basis for evaluation: a shared water-based formulation with defined viscosity and pH ranges, three distinct formats addressing different application needs, and consistent safety and storage parameters across the range. Whether the priority is the moisturizing emphasis of Relieve Burn Gel, the water-evaporation cooling mechanism of Burn Dressing, or the airborne contamination protection and CE-documented compliance of Sterile Burn Gel, each product is built on the same core technology platform, giving users a consistent performance foundation across Roosin Medical's burn and scald emergency care matrix.
https://www.roosin.com/
Roosin Medical Co., Ltd.
